| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 11/11/2010 | US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 11/11/2010 | US20100286219 1, 3-Dihydroimidazoles for Treating Cardiovascular Disorders |
| 11/11/2010 | US20100286210 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 11/11/2010 | US20100286206 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 11/11/2010 | US20100286203 Pharmaceutically acceptable salts of 2--2h-indazole-7-carboxamide |
| 11/11/2010 | US20100286197 Carboxamide Derivatives As Therapeutic Agents |
| 11/11/2010 | US20100286183 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity |
| 11/11/2010 | US20100286174 Inhibiting gsnor |
| 11/11/2010 | US20100286165 Substituted oxindole compounds |
| 11/11/2010 | US20100286161 Pyrazine derivatives and their use as potassium channel modulators |
| 11/11/2010 | US20100286160 Substituted piperazines as cb1 antagonists |
| 11/11/2010 | US20100286158 Dihydropyrimidinones |
| 11/11/2010 | US20100286150 Levosimendan for use in treating chronic valvular disease |
| 11/11/2010 | US20100286149 Novel benzamide derivatives useful as potassium channel modulators |
| 11/11/2010 | US20100286146 Carboxamide compounds and their use as calpain inhibitors |
| 11/11/2010 | US20100286137 Method of Treating Conditions Involving PPAR-Receptors with Indole Compounds |
| 11/11/2010 | US20100286136 Dihydronaphthyridinyl and related compounds for use in treating ophthalmological disorders |
| 11/11/2010 | US20100286133 Diacyl indazole derivatives as lipase and phospholipase inhibitors |
| 11/11/2010 | US20100286129 Novel benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 11/11/2010 | US20100286128 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine-receptor ligands |
| 11/11/2010 | US20100286123 Inhibitors of the renal outer medullary potassium channel |
| 11/11/2010 | US20100286112 Compounds for the treatment of metabolic disorders |
| 11/11/2010 | US20100286110 Azetidinyl g-protein coupled receptor agonists |
| 11/11/2010 | US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses |
| 11/11/2010 | US20100286095 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 11/11/2010 | US20100286087 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 11/11/2010 | US20100286079 Composition comprising covalent conjugates of chitosan and an acidic drug and parenteral administration |
| 11/11/2010 | US20100286063 GNRH agonist combination drugs |
| 11/11/2010 | US20100286060 Specific binding agents of human angiopoeitin-2 |
| 11/11/2010 | US20100286051 MEMORY AND LEARNING IMPAIRMENTS ASSOCIATED WITH DISRUPTION OF EPHRIN RECEPTOR A6 (EphA6) GENE |
| 11/11/2010 | US20100286050 Method of preventing progression of hypertension-induced heart failure with pkc peptides |
| 11/11/2010 | US20100286048 Albumin Fusion Proteins |
| 11/11/2010 | US20100286037 Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase |
| 11/11/2010 | US20100286029 Use of a peptide as a therapeutic agent |
| 11/11/2010 | US20100286028 Use of a peptide as a therapeutic agent |
| 11/11/2010 | US20100286025 Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| 11/11/2010 | US20100286024 Insulinotropic compounds and uses thereof |
| 11/11/2010 | US20100285164 Orally Disintegrating Excipient |
| 11/11/2010 | US20100285156 Composition for preventing and treating metabolic diseases comprising the extract of lysimachiae foenum-graeci herba |
| 11/11/2010 | US20100285145 Gpr 119 modulators |
| 11/11/2010 | US20100285125 Delivery system for poorly soluble drugs |
| 11/11/2010 | US20100285117 Combination of triazine derivatives and insulin sensitisers |
| 11/11/2010 | US20100285089 Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon |
| 11/11/2010 | US20100285085 Balloon coating with drug transfer control via coating thickness |
| 11/11/2010 | US20100285082 Integrated Biosensor and Simulation System for Diagnosis and Therapy |
| 11/11/2010 | US20100285073 a micro-rna family that modulates fibrosis and uses thereof |
| 11/11/2010 | US20100285033 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF |
| 11/11/2010 | US20100285015 Targeting recombinant therapeutics to circulating red blood cells |
| 11/11/2010 | US20100284992 Phospholipase C and Method of Use |
| 11/11/2010 | US20100282622 Solid formulations of prostacyclin analogs |
| 11/11/2010 | CA2761009A1 Compounds and methods for inhibition of renin, and indications therefor |
| 11/11/2010 | CA2760877A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
| 11/11/2010 | CA2758994A1 Antibodies that recognize sulphatides and sulphated proteoglycans and the use thereof |
| 11/10/2010 | EP2248887A1 A method for constructing human placental mesenchymal cells library which is suitable for clinical application |
| 11/10/2010 | EP2248817A2 Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof |
| 11/10/2010 | EP2248816A2 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR ] PYRAZOLO [1,5-A] PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF |
| 11/10/2010 | EP2248815A2 3-sulfonyl-pyrazolo[1,5-a]pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof |
| 11/10/2010 | EP2248814A2 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a] PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF |
| 11/10/2010 | EP2248813A1 Production method and production device for composition having high content of theobromine |
| 11/10/2010 | EP2248811A1 2-oxochromene derivative |
| 11/10/2010 | EP2248805A2 Method of synthesis of bosentan, its polymorphic forms and its salts |
| 11/10/2010 | EP2248523A1 Compounds for use in the treatment of clinical conditions resulting from a deficit of endothelial progenitor cells |
| 11/10/2010 | EP2248520A2 Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
| 11/10/2010 | EP2247584A1 Fused pyridines active as inhibitors of c-met |
| 11/10/2010 | EP2247575A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 11/10/2010 | EP2247571A2 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use |
| 11/10/2010 | EP2247297A2 Therapeutic treatment for lung conditions |
| 11/10/2010 | EP2247183A1 Methods and compositions for inhibiting progression to chronic cardiac failure |
| 11/10/2010 | EP2120968B1 Use of d-ribose to treat atrial fibrillations |
| 11/10/2010 | EP1912991B1 Xanthine derivatives as selective hm74a agonists |
| 11/10/2010 | EP1869056B1 Novel 5-substituted 7-amino-ý1,3¨thiazoloý4,5-d¨pyrimidine derivatives |
| 11/10/2010 | EP1732551B1 Perhexilin for treating chronic heart failure |
| 11/10/2010 | EP1653944B1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
| 11/10/2010 | EP1637517B1 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative |
| 11/10/2010 | EP1633340B1 Compounds for the treatment of metabolic disorders |
| 11/10/2010 | EP1589966B1 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods |
| 11/10/2010 | EP1569692B1 Betaine and salicylic acid compositions |
| 11/10/2010 | EP1460995B1 Transdermal transport of compounds |
| 11/10/2010 | EP1401433B1 Azole acid derivatives, alone or in combination, for treating diabetes and dyslipidemias; and for treating malignant diseases |
| 11/10/2010 | CN201625211U Tablet capsule filled with Dihydroergocryptine mesylate A tablet and caffeine tablet |
| 11/10/2010 | CN1943620B Chinese medicine composition for treating cardio-cerabral vascular diseases and its preparing method |
| 11/10/2010 | CN1929856B An agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor |
| 11/10/2010 | CN1829505B The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 11/10/2010 | CN1799549B Process for preparing soybean isoflavone phospholipid composition |
| 11/10/2010 | CN1778354B Chinese medicine dropping ball for coronary heart disease and angina cordis |
| 11/10/2010 | CN1778352B Chinese medicine composition for treating cardiovascular disease |
| 11/10/2010 | CN1778340B Chinese medicine composition for treating coronary heart disease and angina cordis |
| 11/10/2010 | CN1778335B Chinese medicine for treating coronary heart disease and angina cordis |
| 11/10/2010 | CN1692906B Single-chamber, double-layered osmosis pump control-release system with holes on two sides |
| 11/10/2010 | CN1552315B 治疗组合物 The therapeutic composition |
| 11/10/2010 | CN101883575A Guava extract |
| 11/10/2010 | CN101883571A Agent for promoting the secretion of adiponectin and/or inhibiting the decrease in the secretion of adiponectin |
| 11/10/2010 | CN101883565A Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms |
| 11/10/2010 | CN101880701A New method for preparing aprotinin derivatives by using methanol yeast |
| 11/10/2010 | CN101880304A 24(R)-pseudoginsenoside-GQ as well as semisynthesis method and medicinal application thereof |
| 11/10/2010 | CN101880286A Water-soluble amino-acid ester derivative of ginkgolide B |
| 11/10/2010 | CN101880283A Azaindole kinase inhibitors |
| 11/10/2010 | CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases |
| 11/10/2010 | CN101879309A Application of human urinary kallidinogenase in preparing medicine for treating diabetic foot ulcers |
| 11/10/2010 | CN101879306A Application of quasi adiponectin polypeptide segments used in drug for curing hypoxic-ischemic encephalopathy (HIE) |